Evidence map›Paper›PMID 37553017›Full record

ArticleJournal of affective disorders2023

Antidepressant effects of acute sleep deprivation are reduced in highly controlled environments.

Jennifer R Goldschmied, Elaine Boland, Emma Palermo, Holly Barilla, David F Dinges, John A Detre, Mathias Basner, Yvette I Sheline, Hengyi Rao, Philip Gehrman

Abstract read
In one paragraph

Article in Journal of affective disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Role of Sleep in Depressive Disorders and the Potential Therapeutic Role of Short-Term Sleep Deprivation and Light Therapy: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jennifer R GoldschmiedDepartment of Psychiatry, University of Pennsylvania, 3535 Market St., Philadelphia, PA 19104, United States. Electronic address: jrgolds2@pennmedicine.upenn.edu.
Elaine BolandDepartment of Psychiatry, University of Pennsylvania, 3535 Market St., Philadelphia, PA 19104, United States; Behavioral Health Service, Cpl. Michael J. Crescenz VA Medical Center, 3900 Woodland Ave., Philadelphia, PA 19104, United States. Electronic address: bolande@pennmedicine.upenn.edu.
Emma PalermoDepartment of Psychiatry, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114, United States. Electronic address: ehpalermo@mgh.harvard.edu.
Holly BarillaDepartment of Psychiatry, University of Pennsylvania, 3535 Market St., Philadelphia, PA 19104, United States. Electronic address: holly.barilla@pennmedicine.upenn.edu.
David F DingesDepartment of Psychiatry, University of Pennsylvania, 3535 Market St., Philadelphia, PA 19104, United States. Electronic address: dinges@pennmedicine.upenn.edu.
John A DetreDepartment of Neurology, University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104, United States. Electronic address: detre@pennmedicine.upenn.edu.
Mathias BasnerDepartment of Psychiatry, University of Pennsylvania, 3535 Market St., Philadelphia, PA 19104, United States. Electronic address: basner@pennmedicine.upenn.edu.
Yvette I ShelineDepartment of Psychiatry, University of Pennsylvania, 3535 Market St., Philadelphia, PA 19104, United States. Electronic address: sheline@pennmedicine.upenn.edu.
Hengyi RaoDepartment of Neurology, University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104, United States. Electronic address: hengyi@pennmedicine.upenn.edu.
Philip GehrmanDepartment of Psychiatry, University of Pennsylvania, 3535 Market St., Philadelphia, PA 19104, United States; Behavioral Health Service, Cpl. Michael J. Crescenz VA Medical Center, 3900 Woodland Ave., Philadelphia, PA 19104, United States. Electronic address: philip.gehrman@pennmedicine.upenn.edu.

Funding

Neural mechanisms underlying the antidepressant effects of sleep deprivationR01MH107571 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GEHRMAN, PHILIP RICHARD, RAO, HENGYI · 2016 to 2019
$2.6M
Investigating the Role of Slow-wave Activity as a Marker of Impaired Plasticity in Major Depressive DisorderK23MH118580 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GOLDSCHMIED, JENNIFER RACHEL · 2019 to 2022
$732k
The Role of Effort Discounting in the Link between Insomnia and DepressionIK2CX001501 · VA · PHILADELPHIA VA MEDICAL CENTER · PI BOLAND, ELAINE M · 2017 to 2022
–
CSRD VA IK2 CX001501NIMH NIH HHS K23 MH118580NIMH NIH HHS R01 MH107571
6 · The paper itself

Abstract

backgroundNumerous studies summarized in a recent meta-analysis have shown sleep deprivation rapidly improves depressive symptoms in approximately 50 % of individuals with major depressive disorder (MDD), however those studies were typically conducted in clinical settings. Here we investigated the effects of sleep deprivation utilizing a highly controlled experimental approach.

methods36 antidepressant-free individuals with MDD and 10 healthy controls (HC) completed a 5 day/4-night protocol consisting of adaptation, baseline, total sleep deprivation (TSD), and recovery phases. Light was kept consistently dim (≤50 lx), meals were regulated, and activity was restricted. In-the-moment mood was assessed using a modified Hamilton Rating Scale for Depression (HRSD) at screening and each morning following the experimental nights.

resultsDay of study had a significant effect on mood in both groups. Post-hoc analyses revealed that significant effects were attributed to mood improvement in the MDD group following study initiation prior to beginning TSD, and in the HC group following recovery sleep, but were not due to mood improvement in the MDD group during TSD. No further improvement in mood occurred during 36 h of TSD. LIMITATIONS: Strict eligibility requirements may limit generalizability. The requirement to be medication free may have biased toward a less severely depressed sample.

conclusionsResults revealed that individuals with moderate MDD can experience a significant reduction in depressive symptoms upon entering a highly controlled laboratory environment. Environmental effects on mood can be substantial and need to be considered.

Indexed as

Major Depressive DisorderSleep DeprivationAffectAntidepressive AgentsHumansSleepAntidepressive AgentsMajor depressive disorderMoodSleep deprivation

Identifiers

PMID37553017
PMCPMC10528033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.